共 359 条
[51]
Periaswamy B(2021)Immune responses to Front Immunol 13 undefined-undefined
[52]
De Sessions PF(2019) membrane-associated antigens including alpha-crystallin can potentially discriminate between latent infection and active tuberculosis disease J Infect 341 undefined-undefined
[53]
Lin W(2015)Treatment of latent tuberculosis infection—an update EBioMedicine. 6 undefined-undefined
[54]
Molton JS(2019)Use of isoniazid monotherapy in comparison to rifamycin-based regimen for the treatment of patients with latent tuberculosis: a systematic review Thorax. 14 undefined-undefined
[55]
Naftalin CM(2021)Four months of rifampicin monotherapy for latent tuberculosis infection in children Bioengineered 45 undefined-undefined
[56]
Paton NI(2021)Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis Front Immunol. 108 undefined-undefined
[57]
Migliori GB(2022)Serum biomarker profile including CCL1, CXCL10, VEGF, and adenosine deaminase activity distinguishes active from remotely acquired latent tuberculosis Front Immunol 87 undefined-undefined
[58]
Ong CW(2010)Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages BMJ. 252 undefined-undefined
[59]
Petrone L(2016) infection Front Cell Infect Microbiol undefined undefined-undefined
[60]
D'Ambrosio L(2015)A Genet Mol Res undefined undefined-undefined